The Patent Finder

Actinium Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Actinium Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.

Showing 1 to 6 of 6 · Back to Actinium Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,127,527Apparatus for the therapeutic use of .sup.213 Bi
Lapsed on the fee record
Ended Oct 3, 2012 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2012From the USPTO record
US 7,374,936Method and means for site directed therapy
Term ended
Term ended Mar 23, 2012 · From the USPTO record
Term endedTerm ended Mar 23, 2012From the USPTO record
US 6,403,771Method and means for site directed therapy
Term ended
Ended no later than Feb 19, 2011 · From the USPTO record
Term endedEnded no later than Feb 19, 2011From the USPTO record
US 5,246,691Radioimmunotherapy using .alpha.-particles emission
Term ended
Term ended no later than Sep 21, 2013 · Low confidence
Term endedTerm ended no later than Sep 21, 2013Low confidence
US 5,457,323Process for stripping radon-220 from radioactive isotope mixture
Term ended
Term ended no later than Oct 10, 2015 · Low confidence
Term endedTerm ended no later than Oct 10, 2015Low confidence
US 5,641,471Method for preparing .sup.213 Bi for therapeutic use
Formerly held
Term ended
Term ended no later than Jun 24, 2017 · Low confidence
Term endedTerm ended no later than Jun 24, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited